Long-term follow up of the CLL2007FMP trial evaluating fludarabine and cyclophosphamide in combination with either rituximab or alemtuzumab in previously untreated patients with chronic lymphocytic leukemia.
Haematologica
; 103(7): e304-e306, 2018 07.
Article
in En
| MEDLINE
| ID: mdl-29545348
Full text:
1
Database:
MEDLINE
Main subject:
Leukemia, Lymphocytic, Chronic, B-Cell
/
Antineoplastic Combined Chemotherapy Protocols
Limits:
Humans
Language:
En
Year:
2018
Type:
Article